FDA 483 - L'Oreal USA Products Inc - February 15, 2024

An FDA inspection of L'Oreal USA Products Inc in Somerset, NJ, identified one observation related to the firm's quality control unit. The observation noted that finished goods testing documentation, including for CeraVe Skin Renewing Day Cream SPF30, was recorded on uncontrolled papers lacking dates, traceability, and QC review. This indicates a failure to fully follow established procedures for record control.